Get ready for an exciting launch as Blue Origin's New Glenn rocket prepares to carry NASA's twin Mars satellites, ESCAPADE, into space on Nov. 9! This mission aims to unlock the mysteries of Mars' atmosphere and pave the way for future human exploration.
Pauline Collins, renowned for her Oscar-nominated role in 'Shirley Valentine', has passed away at 85 after battling Parkinson's. Her legacy includes unforgettable performances in theater and film.
Meghan Markle is making her return to the big screen with a cameo in the upcoming film 'Close Personal Friends.' The Duchess of Sussex, known for her role in 'Suits,' continues to engage in various creative projects.
KPop Demon Hunters fans face a long wait for the sequel, set to release in 2029. With Netflix capitalizing on the film's success, what can fans expect in the meantime?
Bruce Willis was spotted looking every bit the Hollywood star during a rare outing in Los Angeles. Despite his recent diagnosis of frontotemporal dementia, he appears to be in great spirits and health, as family and friends honor him at a benefit concert.
Astronomers have successfully captured breathtaking images of the interstellar comet 3I/ATLAS, revealing its unique features. Thanks to China's Tianwen-1 orbiter, this 10-billion-year-old time capsule is shedding light on the mysteries of our universe.
Blue Origin is gearing up for the second launch of its New Glenn rocket on November 9. This time, it will carry NASA's ESCAPADE spacecraft to Mars, ensuring a careful approach after the first flight's partial success.
SpaceX has successfully launched another batch of Starlink satellites, bringing its total to 2,600 in 2025. The Falcon 9 rocket's booster made its eighth flight and landed perfectly at sea!
The November full moon, known as the Beaver Moon, dazzled stargazers on Nov. 5, 2025, with breathtaking views captured across the globe. From iconic landmarks to serene landscapes, photographers showcased the moon's brilliance. Don't miss the chance to see the near-full moon in the coming nights!
Eli Lilly & Co. and Novo Nordisk A/S have struck a deal with the Trump administration to lower prices for their popular weight-loss drugs, Zepbound and Wegovy, while gaining tariff relief and expanding Medicare access. This agreement aims to increase availability for older Americans.
